Germany
Initial notification · 11.08.2026
Supply shortage: Neotri
Affected country: Germany · Reported period: 05.08.2026 – 30.04.2027 · Active ingredient: Triamteren; Xipamid
CountryGermany
PZN02481110
ENR2102405
Notification typeInitial notification
Start05.08.2026
Expected end30.04.2027
Last update11.08.2026
ReasonOther
ATCC03EA
Hospital-relevantNo
Notice context
A supply shortage has been recorded for Neotri in Germany. The stated reason is “Other”. The notice concerns the active ingredient Triamteren; Xipamid and is not identified as hospital-relevant.
This information describes the reported supply status and is not medical or pharmaceutical treatment advice. Availability, alternatives and further measures must be assessed for each individual case by the responsible pharmaceutical market participants.
Primary source: PharmNet.Bund / BfArM
Official shortage notice for Germany. Responsibility and update procedures follow the information supplied by the relevant authority.
Check the official notice list →